3W Partners
8
62M
7
2
0.12
1
- Stages of investment
- Areas of investment
Summary
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Health Care, Big Data. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Twist Bioscience, WuXi NextCODE.
The important activity for fund was in 2017. The increased amount of exits for fund were in 2018. Opposing the other organizations, this 3W Partners works on 38 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the 3W Partners, startups are often financed by Asset Management Ventures (AMV), ARCH Venture Partners, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are YF Capital (Yunfeng Capital), Temasek Holdings, Sequoia Capital. In the next rounds fund is usually obtained by YF Capital (Yunfeng Capital), Temasek Holdings, Sequoia Capital.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 2
- Exits
- 1
- Follow on index
- 0.12
- Investments by industry
- Health Care (5)
- Biotechnology (5)
- Genetics (2)
- Health Diagnostics (2)
- Big Data (2) Show 14 more
- Investments by region
-
- United States (4)
- China (3)
- Canada (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| LifeMine Therapeutics | 23 Mar 2022 | Biotechnology, Life Science, Therapeutics | Late Stage Venture | 175M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.